Stay updated with breaking news from Michael Mitchell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
LACLEDE COUNTY, Mo. — The Missouri State Highway Patrol is relying on help from the public to identify the vehicle that ran over a woman from Republic in Laclede County on Sept. 16. The crash happened on I-44 near Lebanon. Crystal Hassett was a passenger in a vehicle when the driver overcorrected and overturned, ejecting […]
In recent years, cancer researchers have hailed the arrival of chimeric antigen receptor T cell (CAR T) therapy, which has delivered promising results, transforming the fight against various forms of cancer. The process involves modifying patients' T-cells to target cancer cells, resulting in remarkable success rates for previously intractable forms of cancer.
Look back at a piece of literary history as you uncover why JD Salinger's classic novel was once banned in Washington state.
Chimeric Antigen Receptor T-cell (CAR T) therapy has delivered promising results, transforming the fight against various forms of cancer, but for many, the therapy comes with severe and potentially lethal side effects. Now a research team led by Michael Mitchell of the University of Pennsylvania has found a solution that could help CAR T therapies reach their full potential while minimizing severe side effects.
Palmerston island may soon be rat-free.